ZLAB News and Press, Zai Lab Limited From 03/22/24

A look at the top 10 most actives in the United States Biolase Inc. (BIOL) rose 52.0% to $0.228 on volume of 76,448,685 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 8.5% to $0.1476 on volume of 32,191,096 shares Nova Lifestyle Inc (NVFY) rose 121.6% to $4.1 on volume of 32,...

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) rose 0.1% to $0.1331 on volume of 235,074,479 shares Jaguar Health Inc. (JAGX) rose 16.0% to $0.0799 on volume of 189,600,392 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 2.5% to $0.0205 on volume of 17...

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 28.7% to $0.0887 on volume of 95,670,653 shares BYND Cannasoft Enterprises Inc. (BCAN) rose 21.5% to $0.0243 on volume of 91,833,714 shares Oblong Inc. (OBLG) rose 45.2% to $0.19605 on volume of 60,847,1...

ZL-1310 is an innovative ADC targeting DLL3, a promising therapeutic target in small cell lung cancer and other DLL3 + solid tumors Data will be shared in a poster presentation at the European Lung Cancer Congress 2024 (ELCC 2024) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) t...

2024-03-13 08:29:15 ET Read the full article on Seeking Alpha For further details see: KB Financial, BeiGene, Legend Biotech among premarket gainers' pack

- Findings will be shared in oral presentations at the 2024 Congress of the European Society of Gynaecological Oncology (ESGO) and the 2024 Society for Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer - Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that th...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conference in March 2024: Leerink Partners Global Biopharma Conference 2024 Presentation: Monday, March 11, 2024, 4:00 p.m. E...

Total product revenue of $266.7 million for Full-Year 2023, representing 25% y-o-y growth; 31% y-o-y growth at constant exchange rate (CER) VYVGART ® (efgartigimod alfa injection) was launched in September 2023 in China and we estimate that nearly 1,000 patients were treated ...

2024-02-13 17:50:10 ET More on Zai Lab Zai Lab: Strong Growth Amidst Strategic Shifts (Rating Upgrade) NovoCure Tumor Treating Fields accepted for FDA review Zai Lab, argenx gain as China adds Vyvgart for reimbursement Seeking Alpha’s Quant Rating on Z...

A look at the top 10 most actives in the United States Palantir Technologies Inc. Class A (PLTR) rose 7.9% to $23.6 on volume of 254,911,069 shares MicroCloud Hologram Inc. (HOLO) rose 1092.1% to $18 on volume of 194,069,467 shares Snap Inc. Class A (SNAP) fell 34.6% to $11.41 on volume o...